Inoviq Ltd

Research Inoviq Ltd (IIQ) on Bullrun: market cap AUD 76.72M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerIIQ
• ExchangeAU
• CountryAustralia
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyAUD
• Market capAUD 76.72M
• Financial periodFY2024
• RevenueAUD 535.12K
• Revenue growth34.4%
• Net income-AUD 6.55M
• Free cash flow-AUD 4.50M
• Gross margin84.9%

Valuation Snapshot

latest market cap is AUD 76.72M.

About Inoviq Ltd

INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an EV isolation tool for biomarker discovery and diagnostic development.

Frequently asked questions

What is Inoviq Ltd's market cap?

Inoviq Ltd's market capitalization is AUD 76.72M.

What does Inoviq Ltd do?

INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer;